Welcome to Aquilon Pharma
Aquilon Pharma started in 2013 as a spin-off of Liège University (Belgium) and is now an independent and multidisciplinary PharmaTech company with global ambitions, specialized in the improvement of the efficacy of drugs through inhalation.
We are reformulating drugs with Cyclodextrin as functional recipient to make inhaled drugs much more efficient through better lung disposition.
Aquilon Pharma has developed a breakthrough functional recipient technology that improves the pharmacology and the lung deposition of existing drugs. Our formulations, inhalation solutions and powders, are compatible with most of the existing and innovative inhalation devices.
Our core identity
Our portfolio of products
Aquilon Pharma has a diversified development pipeline.
Aquilon Pharma has a multidisciplinary team with strong expertise and experience.